Reuters: Health
The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
Remdesivir close to EU's initial authorisation as COVID-19 treatment
Remdesivir close to EU's initial authorisation as COVID-19 treatment
Reuters: Health
The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
Reuters: Health
The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment